The 20 Best Retinitis Pigmentosa Doctors Near Me in Flushing, NY

Mark Travor is an Ophthalmologist practicing medicine in Cooperstown, New York. Dr. Travor is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. His clinical expertise encompasses Usher Syndrome, Retinitis Pigmentosa, and Retinopathy Pigmentary Mental Retardation.

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Paul Hahn is an Ophthalmologist practicing medicine in Nanuet, New York. Dr. Hahn is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Hahn is board certified in American Board Of Ophthalmology.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Usher Syndrome, and Usher Syndrome Type 2A.

Dr. Maisel, founder of the Retina Group of New York, is a board-certified ophthalmologist who completed the Dyson fellowship in Vitreous and Retinal surgery at New York Presbyterian Hospital-Cornell Medical Center. He has received a Special Congressional Award for his work in diabetic retinopathy and the Banko Gift of Sight Award. He also was named the Juvenile Diabetes Research Foundation Humanitarian of the Year.He has served as a Corporate Advisory Board member for the Foundation of the American Academy of Ophthalmology (AAO) and the Juvenile Diabetes Foundation Medical Advisory Board. He was also a member of the AAO Instrument and Device and Low Vision Committees and has received research grants from the U.S. Public Health Service and the National Institute of Health. Dr. Maisel represented the National Society to Prevent Blindness at the ANSI Z-80 committee where he helped establish many ophthalmic industry standards. He served as an editor of EyeCare Technology Magazine and co-editor of Diabetes Technology Magazine. He also authored numerous professional journal articles and lectures nationally on the retina, medical informatics, and practice management topics. In addition, he has been a clinical investigator, consultant, educator, and advisory board member for Pfizer, Novartis, Genentech, Alimera, Regeneron, and Allergan, educating retinal specialists across the US.Dr. Maisel specializes in diabetic retinopathy, macular degeneration, retinal tears and retinal detachment, macular pucker and macular hole repair, uveitis, ophthalmic surgical complications, hereditary retinal conditions, electrophysiology, glaucoma and second opinions. Dr. Maisel is rated as undefined provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Artery Occlusion, Cataract Removal, and Vitrectomy. Dr. Maisel is board certified in American Board Of Ophthalmology. Dr. Maisel is currently accepting new patients.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy. Dr. Brodie is currently accepting new patients.

Eric Shakin is an Ophthalmologist practicing medicine in Westbury, New York. Dr. Shakin is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Vitrectomy. Dr. Shakin is board certified in American Board Of Ophthalmology.

Dr. Zagelbaum is a Diplomate of the American Board of Ophthalmology (board certified) and a Fellow of the American College of Ophthalmology (F.A.A.O.) and the American College of Surgeons (F.A.C.S.). He has written textbooks in ophthalmology, as well as book chapters and peer reviewed articles. He is currently co-editing the 3rd edition of the textbook Ophthalmic Surgical Procedures.His main interests include eye trauma and sports. He is the ophthalmology consultant to The National Football League (NFL) and The Boxing/Mixed Martial Arts Commission. He has been the team ophthalmologist for the New York Jets, New York Mets, New York Islanders, and has worked with Major League Baseball (MLB) and the National Basketball Association (NBA). Dr. Zagelbaum is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Optic Nerve Atrophy, Optic Atrophy Type 1, Glaucoma, and Eyelid Bump. Dr. Zagelbaum is board certified in American Board Of Ophthalmology.

Richard Rosen is an Ophthalmologist practicing medicine in New York, New York. Dr. Rosen is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Vitrectomy.

Larry Koreen is an Ophthalmologist practicing medicine in Newburgh, New York. Dr. Koreen is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Retinal Artery Occlusion, and Vitrectomy.

Tarun Sharma is an Ophthalmologist practicing medicine in New York, New York. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Late-Onset Retinal Degeneration, X-Linked Juvenile Retinoschisis, Vitrectomy, and Trabeculectomy. Dr. Sharma is currently accepting new patients.

Howard Charles is an Ophthalmologist practicing medicine in Mount Kisco, New York. Dr. Charles is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Diabetic Retinopathy. Dr. Charles is board certified in American Board Of Ophthalmology.

Sherry Solomon is an Ophthalmologist practicing medicine in Scarsdale, New York. Dr. Solomon is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Retinitis Pigmentosa, X-Linked Retinitis Pigmentosa (XLRP), Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Golnaz Moazami is an Ophthalmologist practicing medicine in New York, New York. Dr. Moazami is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Optic Nerve Atrophy, Optic Atrophy Type 1, Ocular Hypertension (OHT), and Fourth Cranial Nerve Palsy. Dr. Moazami is board certified in American Board Of Ophthalmology.

David Poon is an Ophthalmologist practicing medicine in Rockville Centre, New York. Dr. Poon is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, and Retinal Vein Occlusion. Dr. Poon is board certified in American Board Of Ophthalmology.

Yu Hyon Kim, MD, is an attending physician, Retina and Assistant Professor, Ophthalmology & Visual Sciences at Montefiore Einstein. His clinical focus is in all aspects of vitreoretinal diseases evaluation, treatment and surgery, with a special interest in retinovascular disease, diabetes, macular degeneration, sickle cell and vascular occlusions. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Retinal Artery Occlusion, Retinal Detachment, and Retinal Vein Occlusion.

Philip Ferrone is an Ophthalmologist practicing medicine in Elmhurst, New York. Dr. Ferrone is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Coats Disease, and Vitrectomy. Dr. Ferrone is board certified in American Board Of Ophthalmology.

Henry Oksman is an Ophthalmologist practicing medicine in White Plains, New York. Dr. Oksman is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Blepharitis, Interstitial Keratitis, Glaucoma, and Retinitis Pigmentosa.

David C. Ritterband MD, FACS is a Professor of Ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Prior to joining Manhattan Eye, Ear and Throat Hospital (MEETH)/Northwell Eye Institute, he was a Professor of Ophthalmology at the Icahn School of Medicine at Mt Sinai and System Director of the Refractive Surgery Service for the Mount Sinai Health System. At MEETH he has assumed leadership of the Refractive Surgery division and the Laser Vision Correction Center and sees patients at the Manhattan Eye, Ear and Throat Hospital on 64th Street. Dr. Ritterband is a graduate of Duke University and received his medical degree at New York Medical College where he was elected to Alpha Omega Alpha, the national medical honor society. He completed his Ophthalmology Residency at New York Medical College where he was elected Chief Resident. He completed his Corneal and External disease and Refractive Surgery Fellowship at the University of Pittsburgh School of Medicine Eye and Ear Institute. He is a fellow of the American Academy of Ophthalmology and the American College of Surgeons. He is a past president of the Ocular Microbiology and Immunology Group and a long time Medical Board member of the Eye Bank for Sight Restoration in New York City, the world's first Eye Bank. In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Ritterband is a nationally recognized physician, scientist, and surgeon. He has published over 250 medical and scientific papers, book chapters, monographs, and research abstracts. He has lectured widely in the United States on cornea, cataract, and refractive surgery topics. His clinical and research interests include cornea transplantation, cataract surgery, ocular drug development, laser refractive surgery, and ocular infections. A committed teacher and mentor, he has trained over 50 clinical cornea fellows first at the highly regarded AUPO certified corneal fellowship program at the New York Eye and Ear Infirmary and continuing with the current AUPO corneal fellowship program at Manhattan Eye, Ear and Throat Hospital. Dr. Ritterband has received numerous awards including an Honor Award from the American Academy of Ophthalmology and has been named multiple times to New York Magazine's Best Doctors, Castle Connolly's Top Doctors, and the NY Times Magazine's Super Doctors. In addition, while at the New York Eye and Ear Infirmary he received 6 Resident Outstanding Teaching and Dedicated Service Awards. Dr. Ritterband is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Cataract, Endophthalmitis, Interstitial Keratitis, Corneal Transplant, and Trabeculectomy. Dr. Ritterband is board certified in American Board Of Ophthalmology.

Saadia Rashid is an Ophthalmologist practicing medicine in Bronx, New York. Dr. Rashid is rated as an Experienced provider by MediFind in the treatment of Retinitis Pigmentosa. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration.